Savant Capital’s DexCom DXCM Stock Holding History

Savant Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	-$2.52M	–	606
2022 Q3	–	Hold	0	–	–	–	126
2022 Q2	–	Sell	-1,200	Closed	-$110K	–	537
2022 Q1	$153K	Hold	1,200	–	–	0.01%	554
2021 Q4	$161K	Hold	1,200	–	–	0.01%	547
2021 Q3	$164K	Hold	1,200	–	–	0.01%	507
2021 Q2	$128K	Hold	1,200	–	–	0.01%	488
2021 Q1	$108K	Hold	1,200	–	–	0.01%	461
2020 Q4	$111K	Buy	+1,200	New	+$107K	0.01%	429

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Savant Capital's DXCM Position: Q1 2026 in Review

Savant Capital increased its DexCom (DXCM) stake by 7.3% in Q1 2026, buying an estimated $73.3K and bringing the position to 15,403 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Savant Capital first reported a position in DXCM in Q2 2013 and has held it in 50 quarters since. The position peaked at $15.9M in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Savant Capital held 15,403 shares of DexCom worth $967K as of Q1 2026.
Savant Capital bought 1,053 DexCom shares in Q1 2026, an estimated $73.3K.
DexCom made up ﹤0.01% of Savant Capital's portfolio in Q1 2026, its #644 holding.
Savant Capital first reported a position in DexCom in Q2 2013 and has held it in 50 quarters since.
Savant Capital's DexCom position peaked at $15.9M in Q3 2021.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.